Overview / Abstract: |
In this 45-minute, case-based, modular activity, Sandra van Calcar, PhD, RD, LD, and Jerry Vockley, MD, PhD, address key topics, including disease presentation, historical treatment, emerging treatment with triheptanoin, and nutritional planning specific to patients with LC-FAODs. Triheptanoin is an odd-carbon MCT designed to bypass the metabolic block in LC-FAODs, recently approved as an alternative treatment option. The faculty discuss the safety and efficacy of triheptanoin and their real-world experience initiating and optimizing it to bridge critical care gaps in patients with LC-FAODs. They briefly orient learners to a downloadable, point-of-care resource for patient education developed as part of this accredited activity. |
Expiration |
Nov 25, 2025 |
Discipline(s) |
Dietetics / Dietitian CE, Nurse Practitioner , Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
0.75 |
Accreditation |
ACCME, ANCC, CA-BRN |
Presenters / Authors / Faculty |
Sandra van Calcar, PhD, RD, LD Jerry Vockley, MD, PhD |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Ultragenyx Pharmaceutical, Inc. This activity is developed in collaboration with Genetic Metabolic Dietitians International (GMDI). |
Keywords / Search Terms |
Annenberg Center for Health Sciences at Eisenhower Carnitine shuttle Clinical features Historical treatment Triheptanoin safety, efficacy Triheptanoin optimization Point-of-care educational resource Free CE CME |